BioCentury
ARTICLE | Clinical News

PEG-hemoglobin oxygen carrier: Began Phase I trial of safety and tolerance

May 8, 1995 7:00 AM UTC

Enzon Inc. (ENZN), Piscataway, N.J. Product: PEG-hemoglobin oxygen carrier Indication: Blood substitute Status: Began Phase I trial of safety and tolerance ...